Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, September 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 113 articles:
HTML format


 

Single Articles

  1. KOPEC G
    Electrocardiography in pulmonary hypertension.
    Pol Arch Intern Med. 2019;129.
    Abstract    



  2. RUFFENACH G, Umar S, Vaillancourt M, Hong J, et al
    Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis.
    EMBO Mol Med. 2019 Aug 29:e10061. doi: 10.15252/emmm.201810061.
    Abstract    

    Abstract available

  3. SINGH N, Shafiq M, Jagavelu K, Hanif K, et al
    A study on the involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension.
    Exp Cell Res. 2019 Aug 26:111569. doi: 10.1016/j.yexcr.2019.111569.
    Abstract    

    Abstract available

  4. PATEL M, Ladak K
    Tattoo Koebnerization and Severe Pulmonary Hypertension.
    Clin Med Res. 2019 Aug 28. pii: cmr.2019.1469. doi: 10.3121/cmr.2019.1469.
    Abstract    



  5. NIIHORI M, Eccles CA, Kurdyukov S, Zemskova M, et al
    Rats with Human Mutation of NFU1 Develop Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019 Aug 28. doi: 10.1165/rcmb.2019-0065.
    Abstract    

    Abstract available

  6. GOHAR A, Shrestha A, Stys A
    Pulmonary Hypertension: Brief Review Article.
    S D Med. 2019;72:218-224.
    Abstract    

    Abstract available

  7. RIVERA-LEBRON BN, Cruz Morel KJ, Risbano MG
    Postural changes from ventilatory gas exchange in pulmonary hypertension: Is it a practical solution to a complex question?
    Respirology. 2019 Aug 27. doi: 10.1111/resp.13691.
    Abstract    



  8. IKEDA N, Hatano M, Nagamatsu T, Nakamura M, et al
    Successful right heart remodelling and subsequent pregnancy in a patient with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty: a case report.
    Eur Heart J Case Rep. 2019;3.
    Abstract    

    Abstract available

  9. QUEZADA CA, Jimenez D
    Cardiopulmonary exercise testing with ventilatory gas analysis for evaluation of chronic thromboembolic pulmonary hypertension: Unmasking its role after a therapeuthic intervention.
    Int J Cardiol. 2019 Aug 14. pii: S0167-5273(19)33472.
    Abstract    



  10. JIANG J, Zhang J, Kang M, Yang J, et al
    Transient hypertrophic cardiomyopathy and hypertension associated with hydrocortisone in preterm infant: A case report.
    Medicine (Baltimore). 2019;98:e16838.
    Abstract    

    Abstract available

  11. FAVOCCIA C, Constantine AH, Wort SJ, Dimopoulos K, et al
    Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease.
    Expert Rev Cardiovasc Ther. 2019;17:449-459.
    Abstract    

    Abstract available

  12. YANG W, Dong M, Rabinovitch M, Chan FP, et al
    Evolution of hemodynamic forces in the pulmonary tree with progressively worsening pulmonary arterial hypertension in pediatric patients.
    Biomech Model Mechanobiol. 2019;18:779-796.
    Abstract    

    Abstract available

  13. ZELT JGE, Mielniczuk LM
    Micro Computed Tomography in Experimental Pulmonary Arterial Hypertension.
    Circ Cardiovasc Imaging. 2018;11:e008631.
    Abstract    



  14. KHAN MS, Usman MS, Siddiqi TJ, Khan SU, et al
    Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
    Circ Cardiovasc Qual Outcomes. 2018;11:e004757.
    Abstract    

    Abstract available

  15. WHITAKER ME, Nair V, Sinari S, Dherange P, et al
    Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.
    Am J Med. 2018 Feb 5. pii: S0002-9343(18)30091.
    Abstract    

    Abstract available

  16. JAFFEY JA, Wiggen K, Leach SB, Masseau I, et al
    Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dogs: Clinical features, diagnostic testing and survival.
    Vet J. 2019;251:105347.
    Abstract    

    Abstract available

  17. TRAN LK, Gross LM, Hagley P, Minkin R, et al
    Pulmonary hypertension in metastatic breast cancer: a case of pulmonary tumour thrombotic microangiopathy.
    BMJ Case Rep. 2019;12.
    Abstract    

    Abstract available

  18. KUSUNOSE K, Yamada N, Yamada H, Nishio S, et al
    Association between Right Ventricular Contractile Function and Cardiac Events in Isolated Post-capillary and Combined Pre- and Post-capillary Pulmonary Hypertension.
    J Card Fail. 2019 Sep 2. pii: S1071-9164(19)30143.
    Abstract    

    Abstract available

  19. ANAND V, Frantz RP, DuBrock H, Kane GC, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience.
    Mayo Clin Proc Innov Qual Outcomes. 2019;3:311-318.
    Abstract    

    Abstract available

  20. MINATSUKI S, Hatano M, Maki H, Takimoto E, et al
    Analysis of Oxygenation in Chronic Thromboembolic Pulmonary Hypertension Using Dead Space Ratio and Intrapulmonary Shunt Ratio.
    Int Heart J. 2019 Sep 4. doi: 10.1536.
    Abstract    

    Abstract available

  21. YOKOKAWA T, Sugimoto K, Yoshihisa A, Goto T, et al
    The Fibrosis-4 Index Is Useful for Predicting Mortality in Patients with Pulmonary Hypertension due to Left Heart Disease.
    Int Heart J. 2019 Sep 4. doi: 10.1536.
    Abstract    

    Abstract available

  22. AKABANE R, Shimano S, Sakatani A, Ogawa M, et al
    Relationship between right heart echocardiographic parameters and invasive pulmonary artery pressures in canine models of chronic embolic pulmonary hypertension.
    J Vet Med Sci. 2019 Sep 4. doi: 10.1292/jvms.19-0350.
    Abstract    

    Abstract available

  23. AKDENIZ B
    [Characteristics of patients with patent ductus arteriosus and/or pulmonary hypertension living at moderate to high altitude and important considerations while performing transcatheter closure].
    Turk Kardiyol Dern Ars. 2019;47:423-426.
    Abstract    



  24. BURNS AT, Hansen SL, Turner ZS, Aden JK, et al
    Prevalence of Pulmonary Hypertension in Pediatric Patients With Obstructive Sleep Apnea and a Cardiology Evaluation: A Retrospective Analysis.
    J Clin Sleep Med. 2019;15:1081-1087.
    Abstract    

    Abstract available

  25. BARCO S, Klok FA, Konstantinides SV, Dartevelle P, et al
    Sex-specific differences in Chronic Thromboembolic Pulmonary Hypertension. Results from the European CTEPH Registry.
    J Thromb Haemost. 2019 Sep 3. doi: 10.1111/jth.14629.
    Abstract    

    Abstract available

  26. BAMFORD P, Lau GT
    Severe, Reversible Pulmonary Hypertension From Giant Pedunculated Left Atrial Myxoma.
    J Invasive Cardiol. 2019;31:E273.
    Abstract    

    Abstract available

  27. XING Y, Zheng X, Fu Y, Qi J, et al
    Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension.
    Mol Ther. 2019 Aug 22. pii: S1525-0016(19)30370.
    Abstract    

    Abstract available

  28. NEMOTO K, Oh-Ishi S, Akiyama T, Yabuuchi Y, et al
    Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
    BMC Pulm Med. 2019;19:167.
    Abstract    

    Abstract available

  29. CHENG X, Wang Y, Du L
    Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.
    Hypertension. 2019 Sep 3:HYPERTENSIONAHA11913458.
    Abstract    

    Abstract available

  30. SCHULTZ A, Olorundami OA, Teng RJ, Jarzembowski J, et al
    Decreased OLA1 (Obg-Like ATPase-1) Expression Drives Ubiquitin-Proteasome Pathways to Downregulate Mitochondrial SOD2 (Superoxide Dismutase) in Persistent Pulmonary Hypertension of the Newborn.
    Hypertension. 2019 Sep 3:HYPERTENSIONAHA11913430.
    Abstract    

    Abstract available

  31. TAN M, Li Z, Tang H, Sun G, et al
    IgG4-Related Tumefactive Lesions at the Pulmonary Artery Causing Stenosis of Bilateral Primary Branches and Resultant Pulmonary Hypertension.
    Cardiology. 2019 Sep 2:1-9. doi: 10.1159/000501741.
    Abstract    

    Abstract available

  32. WANG Y, Wu F, Hu F, Wu Y, et al
    Drag-reducing polymers attenuates pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension.
    Clin Hemorheol Microcirc. 2019 Aug 23. pii: CH190668. doi: 10.3233/CH-190668.
    Abstract    

    Abstract available

  33. OZEN G, Benyahia C, Mani S, Boukais K, et al
    Bronchodilation induced by PGE2 is impaired in Group-III pulmonary hypertension.
    Br J Pharmacol. 2019 Sep 2. doi: 10.1111/bph.14854.
    Abstract    

    Abstract available

  34. AGRAWAL V, D'Alto M, Naeije R, Romeo E, et al
    Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge.
    J Am Heart Assoc. 2019;8:e012504.
    Abstract    

    Abstract available

  35. SEGEL MJ, Kogan A, Preissman S, Agmon-Levin N, et al
    Pulmonary Endarterectomy Surgery for Chronic Thromboembolic Pulmonary Hypertension: A Small-Volume National Referral Center Experience.
    Isr Med Assoc J. 2019;21:528-531.
    Abstract    

    Abstract available

  36. NIVARGI V, Makhale C, Kulkarni V
    Balloon Mitral Valvuloplasty in Mirror Image Dextrocardia with Rheumatic Mitral Stenosis with Suprasystemic Pulmonary Arterial Hypertension.
    J Assoc Physicians India. 2019;67:94-95.
    Abstract    

    Abstract available

  37. YANG YD, Li MM, Xu G, Feng L, et al
    Nogo-B Receptor Directs Mitochondria-Associated Membranes to Regulate Vascular Smooth Muscle Cell Proliferation.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  38. BAI Y, Yang J, Liu J, Ning H, et al
    Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
    Int J Cardiovasc Imaging. 2019;35:1637-1649.
    Abstract    

    Abstract available

  39. PAPOLOS A, Fan E, Wagle RR, Foster E, et al
    Echocardiographic determination of pulmonary arterial capacitance.
    Int J Cardiovasc Imaging. 2019;35:1581-1586.
    Abstract    

    Abstract available

  40. SANTOS-MARTINEZ LE, Lozano-Torres VM, Flores-Garcia CA, Soto-Marquez P, et al
    Pulmonary endarterectomy. Initial report in a cardiology hospital
    Rev Med Inst Mex Seguro Soc. 2019;56:478-485.
    Abstract    

    Abstract available

  41. AGGARWAL M, Grady RM, Choudhry S, Anwar S, et al
    Potts Shunt Improves Right Ventricular Function and Coupling With Pulmonary Circulation in Children With Suprasystemic Pulmonary Arterial Hypertension.
    Circ Cardiovasc Imaging. 2018;11:e007964.
    Abstract    

    Abstract available

  42. KOJONAZAROV B, Belenkov A, Shinomiya S, Wilchelm J, et al
    Evaluating Systolic and Diastolic Cardiac Function in Rodents Using Microscopic Computed Tomography.
    Circ Cardiovasc Imaging. 2018;11:e007653.
    Abstract    

    Abstract available

  43. NIE X, Chen Y, Tan J, Dai Y, et al
    MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Vascul Pharmacol. 2019;116:24-35.
    Abstract    

    Abstract available

  44. TANG Z, Jiang M, Ou-Yang Z, Wu H, et al
    High mobility group box 1 protein (HMGB1) as biomarker in hypoxia-induced persistent pulmonary hypertension of the newborn: a clinical and in vivo pilot study.
    Int J Med Sci. 2019;16:1123-1131.
    Abstract    

    Abstract available

  45. CHEN SC, Dastamani A, Pintus D, Yau D, et al
    Diazoxide-induced Pulmonary Hypertension in Hyperinsulinaemic Hypoglycaemia: Recommendations from a Multicentre Study in the United Kingdom.
    Clin Endocrinol (Oxf). 2019 Sep 14. doi: 10.1111/cen.14096.
    Abstract    

    Abstract available

  46. GUPTA VS, Harting MT
    Congenital diaphragmatic hernia-associated pulmonary hypertension.
    Semin Perinatol. 2019 Jul 30:151167. doi: 10.1053/j.semperi.2019.
    Abstract    

    Abstract available

  47. MIZUNO M, Aso K, Tsuzuki Y, Kitazawa T, et al
    A successful treatment of tadalafil in incontinentia pigmenti with pulmonary hypertension.
    Eur J Med Genet. 2019 Sep 10:103764. doi: 10.1016/j.ejmg.2019.103764.
    Abstract    

    Abstract available

  48. TELLO K, Seeger W, Naeije R, Vanderpool R, et al
    Right heart failure in pulmonary hypertension: Diagnosis and new perspectives on vascular and direct right ventricular treatment.
    Br J Pharmacol. 2019 Sep 13. doi: 10.1111/bph.14866.
    Abstract    

    Abstract available

  49. BROKER J, Cvetkovic D, Yaghoubian S
    Anesthetic management during bronchoscopy of patients with pulmonary hypertension.
    Ann Transl Med. 2019;7:355.
    Abstract    

    Abstract available

  50. CHOWDHURY MA, Moukarbel GV, Gupta R, Frank SM, et al
    Endothelin 1 Is Associated with Heart Failure Hospitalization and Long-Term Mortality in Patients with Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension.
    Cardiology. 2019 Sep 12:1-10. doi: 10.1159/000501100.
    Abstract    

    Abstract available

  51. OBOKATA M, Kane GC, Reddy YNV, Melenovsky V, et al
    The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
    Eur Heart J. 2019 Sep 12. pii: 5568303. doi: 10.1093.
    Abstract    

    Abstract available

  52. YOKOKAWA T, Sugimoto K, Kimishima Y, Misaka T, et al
    A Case of Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia Related to an ACVRL1 Mutation.
    Intern Med. 2019 Sep 11. doi: 10.2169/internalmedicine.3625.
    Abstract    

    Abstract available

  53. ZHAO Y, Wang B, Zhang J, He D, et al
    ALDH2 (Aldehyde Dehydrogenase 2) Protects Against Hypoxia-Induced Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2019 Sep 12:ATVBAHA119312946.
    Abstract    

    Abstract available

  54. GONZALEZ-TAJUELO R, de la Fuente-Fernandez M, Morales-Cano D, Munoz-Callejas A, et al
    PSGL1-deficient mice develop spontaneous pulmonary hypertension associated to systemic sclerosis.
    Arthritis Rheumatol. 2019 Sep 11. doi: 10.1002/art.41100.
    Abstract    

    Abstract available

  55. BERNARDO RJ, Bokan A, Ramjug S
    Updates in pulmonary hypertension and other pulmonary vascular diseases.
    Breathe (Sheff). 2019;15:241-243.
    Abstract    

    Abstract available

  56. YUCEL E, Al-Bawardy R, Bertrand PB
    Pulmonary Hypertension in Patients Eligible for Transcatheter Mitral Valve Repair: Prognostic Impact and Clinical Implications.
    Curr Treat Options Cardiovasc Med. 2019;21:60.
    Abstract    

    Abstract available

  57. UNEGBU C
    Perioperative Considerations in Pediatric Patients With Pulmonary Hypertension.
    Int Anesthesiol Clin. 2019;57:25-41.
    Abstract    



  58. BASHLINE MJ, Simon MA
    Use of Tricuspid Annular Plane Systolic Excursion/Pulmonary Artery Systolic Pressure As a Non-Invasive Method to Assess Right Ventricular-PA Coupling in Patients With Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2019;12:e009648.
    Abstract    



  59. TELLO K, Wan J, Dalmer A, Vanderpool R, et al
    Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2019;12:e009047.
    Abstract    

    Abstract available

  60. HUANG H, Chen D, Pu J, Yuan A, et al
    The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
    Int Immunopharmacol. 2019;76:105874.
    Abstract    

    Abstract available

  61. AGUILAR SA, Arias PV, Canquil I, Ebensperger G, et al
    [Melatonin modulates the expression of pulmonary prostanoids].
    Rev Med Chil. 2019;147:281-288.
    Abstract    

    Abstract available

  62. ZHANG M, Chang Z, Zhang P, Jing Z, et al
    Protective effects of 18beta-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
    Chem Biol Interact. 2019;311:108749.
    Abstract    

    Abstract available

  63. BARNES H, Yeoh HL, Fothergill T, Burns A, et al
    Prostacyclin for pulmonary arterial hypertension.
    Cochrane Database Syst Rev. 2019;5:CD012785.
    Abstract    

    Abstract available

  64. SHYUR SD
    Reply - Cystic fibrosis complicated by cor pulmonale: The first case report in Taiwan.
    Pediatr Neonatol. 2019;60:352-353.
    Abstract    



  65. MOSLEHI MA
    Cystic fibrosis complicated by cor pulmonale: The first case report in Taiwan.
    Pediatr Neonatol. 2019;60:351.
    Abstract    



  66. GANDHI S, Eckstein J, Fam N, Edwards J, et al
    Transfemoral mitral valve-in-valve implantation for prosthetic mitral regurgitation.
    Eur Heart J Cardiovasc Imaging. 2019;20:485.
    Abstract    



  67. LIU HM, Jia Y, Zhang YX, Yan J, et al
    Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
    Acta Pharmacol Sin. 2019;40:477-485.
    Abstract    

    Abstract available

  68. FAN Y, Guo X, Sun X, Cao X, et al
    [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31:972-977.
    Abstract    

    Abstract available

  69. WEDGWOOD S, Warford C, Agvatisiri SR, Thai PN, et al
    The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model.
    Pediatr Res. 2019 Sep 19. pii: 10.1038/s41390-019-0578.
    Abstract    

    Abstract available

  70. MIYAWAKI H, Kioka H, Sato K, Kurashige M, et al
    Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis.
    Intern Med. 2019 Sep 18. doi: 10.2169/internalmedicine.3528.
    Abstract    

    Abstract available

  71. HUSTON JH, Maron BA, French J, Huang S, et al
    Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function.
    JAMA Cardiol. 2019 Sep 18. pii: 2751319. doi: 10.1001/jamacardio.2019.3345.
    Abstract    

    Abstract available

  72. CHIN HL, Goh DL, Wang FS, Tay SKH, et al
    A combination of two novel VARS2 variants causes a mitochondrial disorder associated with failure to thrive and pulmonary hypertension.
    J Mol Med (Berl). 2019 Sep 16. pii: 10.1007/s00109-019-01834.
    Abstract    

    Abstract available

  73. JONES C, Bisserier M, Bueno-Beti C, Bonnet G, et al
    A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism.
    Cardiovasc Res. 2019 Sep 14. pii: 5569883. doi: 10.1093.
    Abstract    

    Abstract available

  74. AHMADIPOUR B, Khajali F
    Expression of antioxidant genes in broiler chickens fed nettle (Urtica dioica) and its link with pulmonary hypertension.
    Anim Nutr. 2019;5:264-269.
    Abstract    

    Abstract available

  75. DAROCHA S, Banaszkiewicz M, Pietrasik A, Siennicka A, et al
    Changes in Estimated Glomerular Filtration after Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Cardiorenal Med. 2019 Sep 17:1-10. doi: 10.1159/000502254.
    Abstract    

    Abstract available

  76. CATELLA-CHATRON J, Merah A, De Magalhaes E, Moulin N, et al
    Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancer patients.
    Respir Med Res. 2019;76:34-37.
    Abstract    

    Abstract available

  77. JACHEC W, Tomasik A, Kurzyna M, Pietura R, et al
    The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.
    BMC Pulm Med. 2019;19:80.
    Abstract    

    Abstract available

  78. BOHNEN MS, Ma L, Zhu N, Qi H, et al
    Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.
    Circ Genom Precis Med. 2018;11:e002087.
    Abstract    

    Abstract available

  79. SEFERIAN A, Jais X, Savale L, Jevnikar M, et al
    Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension.
    Respir Med Res. 2019;76:48-53.
    Abstract    

    Abstract available

  80. VIEIRA EB, Ota-Arakaki JS, Dal Corso S, Ivanaga I, et al
    Incremental Step Test In Patients With Pulmonary Hypertension.
    Respir Physiol Neurobiol. 2019 Sep 23:103307. doi: 10.1016/j.resp.2019.103307.
    Abstract    

    Abstract available

  81. BUNCLARK K, Newnham M, Chiu YD, Ruggiero A, et al
    A Multicentre study of anticoagulation in operable chronic thromboembolic pulmonary hypertension.
    J Thromb Haemost. 2019 Sep 26. doi: 10.1111/jth.14649.
    Abstract    

    Abstract available

  82. SALLMON H, Moledina S, Albert DC, Beghetti M, et al
    Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension.
    Cardiol Young. 2019 Sep 26:1-5. doi: 10.1017/S104795111900235.
    Abstract    

    Abstract available

  83. KOPEC G, Kurzyna M, Mroczek E, Chrzanowski L, et al
    Data Base of pulmoNary hyPertension in the PoLish population (BNP-PL) - design of the registry.
    Kardiol Pol. 2019 Sep 25. doi: 10.33963/KP.14988.
    Abstract    



  84. GEENEN LW, Baggen VJM, Kauling RM, Koudstaal T, et al
    The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension.
    J Clin Med. 2019;8.
    Abstract    

    Abstract available

  85. SADUSHI-KOLICI R, Lang IM
    Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension.
    Expert Rev Respir Med. 2019 Sep 23:1-7. doi: 10.1080/17476348.2019.1652094.
    Abstract    

    Abstract available

  86. CIMEN AO, Emet S
    An easy method for monitoring patients with pulmonary Hypertension: P-wave dispersion.
    Cardiovasc J Afr. 2019;30:1-6.
    Abstract    

    Abstract available

  87. LIU T, Zou XZ, Huang N, Ge XY, et al
    Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension.
    Eur J Pharmacol. 2019 Sep 19:172673. doi: 10.1016/j.ejphar.2019.172673.
    Abstract    

    Abstract available

  88. CHANG CY, Shih HJ, Huang IT, Tsai PS, et al
    Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  89. SHEN Q, Chen W, Liu J, Liang Q, et al
    Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease.
    Life Sci. 2019;232:116546.
    Abstract    

    Abstract available

  90. AGRAWAL V, Hemnes AR
    CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
    Am J Respir Cell Mol Biol. 2019;61:281-283.
    Abstract    



  91. RANARD LS, Mallah WE, Awerbach JD, Abernethy A, et al
    Impact of Pulmonary Hypertension on Survival Following Device Closure of Atrial Septal Defects.
    Am J Cardiol. 2019 Aug 7. pii: S0002-9149(19)30873.
    Abstract    

    Abstract available

  92. WEATHERALD J, Montani D, Humbert M
    Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype.
    Am J Respir Crit Care Med. 2019;200:406-408.
    Abstract    



  93. RICHTER MJ, Peters D, Ghofrani HA, Naeije R, et al
    Evaluation and Prognostic Relevance of Right Ventricular-Arterial Coupling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Sep 20. doi: 10.1164/rccm.201906-1195.
    Abstract    



  94. CRITSER PJ, Higano NS, Tkach JA, Olson ES, et al
    Cardiac MRI Evaluation of Neonatal Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Sep 20. doi: 10.1164/rccm.201904-0826.
    Abstract    

    Abstract available

  95. FRID MG, McKeon BA, Thurman JM, Maron BA, et al
    Immunoglobulin-Driven Complement Activation Regulates Pro-Inflammatory Remodeling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Sep 23. doi: 10.1164/rccm.201903-0591.
    Abstract    

    Abstract available

  96. BONNET S, Paulin R
    Involvement of PFKFB3 in Pulmonary Arterial Hypertension Pathogenesis. Is It All about Glycolysis?
    Am J Respir Crit Care Med. 2019;200:532-534.
    Abstract    



  97. CRAWFORD TC, Leary PJ, Fraser C 3rd, Suarez-Pierre A, et al
    Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
    Chest. 2019 Aug 22. pii: S0012-3692(19)33459-2. doi: 10.1016/j.chest.2019.
    Abstract    

    Abstract available

  98. BRITTAIN EL, Hemnes AR
    Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension.
    Circ Res. 2019;125:467-469.
    Abstract    



  99. NAEIJE R, Chin K
    Differentiating Precapillary From Postcapillary Pulmonary Hypertension.
    Circulation. 2019;140:712-714.
    Abstract    



  100. COCKBAIN B, Price LC, Hind M
    Bony Breathlessness: Reversible Pulmonary Hypertension in Melnick-Needles Syndrome Using Noninvasive Ventilation
    Circulation. 2019;140:880-885.
    Abstract    



  101. KIKUCHI N, Satoh K, Kurosawa R, Yaoita N, et al
    Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.
    Circulation. 2018 Apr 10. pii: CIRCULATIONAHA.117.033113.
    Abstract    

    Abstract available

  102. HU CJ, Poth JM, Zhang H, Flockton A, et al
    Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00378-2019.
    Abstract    

    Abstract available

  103. SAVALE L, Habibi A, Lionnet F, Maitre B, et al
    Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00585-2019.
    Abstract    

    Abstract available

  104. HAARMAN MG, Kerstjens-Frederikse WS, Berger RMF
    The ever-expanding phenotypical spectrum of human TBX4 mutations: from toe to lung.
    Eur Respir J. 2019;54.
    Abstract    



  105. GEENEN LW, Baggen VJM, Kauling RM, Koudstaal T, et al
    Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315111. doi: 10.1136/heartjnl-2019-315111.
    Abstract    

    Abstract available

  106. YU B, Zapol WM, Berra L
    Electrically generated nitric oxide from air: a safe and economical treatment for pulmonary hypertension.
    Intensive Care Med. 2019 Aug 26. pii: 10.1007/s00134-019-05756.
    Abstract    



  107. NASIR BS, Mulvihill MS, Barac YD, Bishawi M, et al
    Single lung transplantation in patients with severe secondary pulmonary hypertension.
    J Heart Lung Transplant. 2019;38:939-948.
    Abstract    

    Abstract available

  108. HANSMANN G, Koestenberger M, Alastalo TP, Apitz C, et al
    2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT.
    J Heart Lung Transplant. 2019;38:879-901.
    Abstract    

    Abstract available

  109. AGGARWAL S, Agarwal P, Natarajan G
    Echocardiographic prediction of severe pulmonary hypertension in neonates undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy.
    J Perinatol. 2019 Aug 30. pii: 10.1038/s41372-019-0442.
    Abstract    

    Abstract available

  110. HOETZENECKER K, Schwarz S, Muckenhuber M, Benazzo A, et al
    Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation.
    J Thorac Cardiovasc Surg. 2018;155:2193-2206.
    Abstract    

    Abstract available

  111. HARBAUM L, Ghataorhe P, Wharton J, Jimenez B, et al
    Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension.
    Thorax. 2019;74:380-389.
    Abstract    

    Abstract available

  112. HAN BG, Kim J, Jung IY, Son JW, et al
    Relationship between volume status and possibility of pulmonary hypertension in dialysis naive CKD5 patients.
    PLoS One. 2019;14:e0221970.
    Abstract    

    Abstract available

  113. KOMPOTIATIS P, Wiley BM, Jentzer JC, Kashani KB, et al
    Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy.
    PLoS One. 2019;14:e0209994.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;